Genes
Oligo Pools
NGS
Variant Libraries
Antibodies
IVDR Solutions
Webinars
Featured Resources
.png)
Genome-wide Screen of SARS-CoV-2 Identifies Hyper-potent siRNAs for Nasal Administration
Precision with a Purpose: Benchmark 659 for Cancer Care - Powered by Twist Bioscience
Decoding Nucleic Acid Language of Cis-Regulatory Elements through High-Throughput Experiment and Deep Learning
Academia Genómica de Twist Bioscience
Achieving Rapid, Low-Input CGP Across Tissue and Liquid Biopsy for Oncology Research at the Garvan Institute
NGSFrom tumor profiling to sequencing results in under 48 hours. See how Dr. Orion Tong's team at the Garvan Institute validated a rapid CGP workflow across FFPE, cfDNA, and gDNA using the Twist Oncology - DNA CGP Panel and Trinity™ Freestyle Fast Hyb Kits for Element Bioscience AVITI™ sequencers.
A High-Throughput Ecosystem to Power AI-Driven Antibody Discovery
BiopharmaThis webinar demonstrates how Twist Bioscience’s high-throughput antibody discovery and validation services accelerate the "Lab-in-the-Loop" workflow, enabling researchers to rapidly build custom variant libraries and seamlessly transition from AI-driven in silico designs to physical wet-lab testing in a matter of weeks.
Modernizing High-Throughput Workflows: A Case Study on Transitioning from Microarrays to NGS
NGS
Rapid, Sensitive Pathogen Detection using Hybridization Capture and Nanopore Sequencing
NGS
Meta-Analysis of 150+ Antibody Discovery Campaigns: Transgenic Mice for Optimized Antibodies - PEGS Europe 2025
Biopharma
Exploration of Natural Product Biosynthetic Enzymes and Chemoenzymatic Synthesis of Complex Molecules
Genes
Engineering Compact Base Editors: AlphaFold-Guided Design Meets Directed Evolution
Oligo Pools
Comparison of emergency department indoor air and citywide wastewater for respiratory and enteric virus surveillance using hybrid-capture viral metagenomics
NGS
Beyond the Bottleneck: Engineering Sensitive Bespoke MRD Assays
NGSIn this roundtable hosted by The Scientist, experts from BloodPAC, Stanford University, and Twist Bioscience unpack the state of tumor-informed MRD research on where the field has landed, what's holding it back, and where it's heading next.
